Literature DB >> 18786920

Phosphoinositide 3-kinases gamma and delta, linkers of coordinate C5a receptor-Fcgamma receptor activation and immune complex-induced inflammation.

Stephanie Konrad1, Syed R Ali, Kristina Wiege, Shahzad N Syed, Linda Engling, Roland P Piekorz, Emilio Hirsch, Bernd Nürnberg, Reinhold E Schmidt, J Engelbert Gessner.   

Abstract

Fcgamma receptors (FcgammaR) and the C5a receptor (C5aR) are key effectors of the acute inflammatory response to IgG immune complexes (IC). Their coordinated activation is critical in IC-induced diseases, although the significance of combined signaling by these two different receptor classes in tissue injury is unclear. Here we used the mouse model of the passive reverse lung Arthus reaction to define their requirements for distinct phosphoinositide 3-kinase (PI3K) activities in vivo. We show that genetic deletion of class IB PI3Kgamma abrogates C5aR signaling that is crucial for FcgammaR-mediated activation of lung macrophages. Thus, in PI3Kgamma(-/-) mice, IgG IC-induced FcgammaR regulation, cytokine release, and neutrophil recruitment were blunted. Notably, however, C5a production occurred normally in PI3Kgamma(-/-) mice but was impaired in PI3Kdelta(-/-) mice. Consequently, class IA PI3Kdelta deficiency caused resistance to acute IC lung injury. These results demonstrate that PI3Kgamma and PI3Kdelta coordinate the inflammatory effects of C5aR and FcgammaR and define PI3Kdelta as a novel and essential element of FcgammaR signaling in the generation of C5a in IC disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18786920      PMCID: PMC2662258          DOI: 10.1074/jbc.M804617200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  Roles of Fc receptors in autoimmunity.

Authors:  Toshiyuki Takai
Journal:  Nat Rev Immunol       Date:  2002-08       Impact factor: 53.106

Review 2.  Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.

Authors:  Laura Barberis; Emilio Hirsch
Journal:  Thromb Haemost       Date:  2008-02       Impact factor: 5.249

3.  C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.

Authors:  Nelli Shushakova; Julia Skokowa; Jurriaan Schulman; Ulrich Baumann; Jörg Zwirner; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 4.  Phosphoinositide 3-kinase in immunological systems.

Authors:  David A Fruman; Lewis C Cantley
Journal:  Semin Immunol       Date:  2002-02       Impact factor: 11.130

5.  Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function.

Authors:  Muriel Laffargue; Ronan Calvez; Peter Finan; Alexandre Trifilieff; Maryse Barbier; Fiorella Altruda; Emilio Hirsch; Matthias P Wymann
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

Review 6.  Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.

Authors:  R Katso; K Okkenhaug; K Ahmadi; S White; J Timms; M D Waterfield
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

7.  Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis.

Authors:  Heinfried H Radeke; Iska Janssen-Graalfs; Eveline N Sowa; Nelli Chouchakova; Julia Skokowa; Fabian Löscher; Reinhold E Schmidt; Peter Heeringa; J Engelbert Gessner
Journal:  J Biol Chem       Date:  2002-04-30       Impact factor: 5.157

8.  Arthritis critically dependent on innate immune system players.

Authors:  Hong Ji; Koichiro Ohmura; Umar Mahmood; David M Lee; Frans M A Hofhuis; Susan A Boackle; Kazue Takahashi; V Michael Holers; Mark Walport; Craig Gerard; Alan Ezekowitz; Michael C Carroll; Michael Brenner; Ralph Weissleder; J Sjef Verbeek; Veronique Duchatelle; Claude Degott; Christophe Benoist; Diane Mathis
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

9.  Characterization of the murine IgG Fc receptor III and IIB gene promoters: a single two-nucleotide difference determines their inverse responsiveness to C5a.

Authors:  Stephanie Konrad; Linda Engling; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Biol Chem       Date:  2007-10-23       Impact factor: 5.157

10.  Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils.

Authors:  Tara M Randis; Kamal D Puri; Hairu Zhou; Thomas G Diacovo
Journal:  Eur J Immunol       Date:  2008-05       Impact factor: 5.532

View more
  20 in total

1.  C5a-regulated CCAAT/enhancer-binding proteins β and δ are essential in Fcγ receptor-mediated inflammatory cytokine and chemokine production in macrophages.

Authors:  Chunguang Yan; Mei Zhu; Jennifer Staiger; Peter F Johnson; Hongwei Gao
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

2.  A selective inhibitor reveals PI3Kγ dependence of T(H)17 cell differentiation.

Authors:  Giovanna Bergamini; Kathryn Bell; Satoko Shimamura; Thilo Werner; Andrew Cansfield; Katrin Müller; Jessica Perrin; Christina Rau; Katie Ellard; Carsten Hopf; Carola Doce; Daniel Leggate; Raffaella Mangano; Toby Mathieson; Alison O'Mahony; Ivan Plavec; Faiza Rharbaoui; Friedrich Reinhard; Mikhail M Savitski; Nigel Ramsden; Emilio Hirsch; Gerard Drewes; Oliver Rausch; Marcus Bantscheff; Gitte Neubauer
Journal:  Nat Chem Biol       Date:  2012-04-29       Impact factor: 15.040

Review 3.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

Review 4.  The biology behind PI3K inhibition in chronic lymphocytic leukaemia.

Authors:  Valentín Ortiz-Maldonado; Marcial García-Morillo; Julio Delgado
Journal:  Ther Adv Hematol       Date:  2015-02

Review 5.  Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Authors:  Inessa Schwab; Falk Nimmerjahn
Journal:  Nat Rev Immunol       Date:  2013-02-15       Impact factor: 53.106

6.  Regulation of alveolar macrophage p40phox: hierarchy of activating kinases and their inhibition by PGE2.

Authors:  Emilie Bourdonnay; Carlos H Serezani; David M Aronoff; Marc Peters-Golden
Journal:  J Leukoc Biol       Date:  2012-04-27       Impact factor: 4.962

Review 7.  The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection.

Authors:  Kimberly A Thomas; Nicole M Valenzuela; Elaine F Reed
Journal:  Trends Mol Med       Date:  2015-03-20       Impact factor: 11.951

Review 8.  Duvelisib: a phosphoinositide-3 kinase δ/γ inhibitor for chronic lymphocytic leukemia.

Authors:  Hima V Vangapandu; Nitin Jain; Varsha Gandhi
Journal:  Expert Opin Investig Drugs       Date:  2017-04-13       Impact factor: 6.206

9.  A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritis.

Authors:  Kutty Selva Nandakumar; Asa Jansson; Bingze Xu; Niclas Rydell; Parvin Ahooghalandari; Lars Hellman; Anna M Blom; Rikard Holmdahl
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

10.  Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells.

Authors:  Jens Schreiner; Dorothee Kretschmer; Juliane Klenk; Michael Otto; Hans-Jörg Bühring; Stefan Stevanovic; Ji Ming Wang; Sandra Beer-Hammer; Andreas Peschel; Stella E Autenrieth
Journal:  J Immunol       Date:  2013-03-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.